| May 31,
2007
Green tea extract may boost blood vessel health
By Stephen Daniells
31/05/2007 - The heart healthy reputation of epigallocatechin
gallate (EGCG), the main extract from green tea, may be due in
part to improvement in blood flow through the vessels, suggests
a clinical trial from the US.
"EGCG acutely improves endothelial function in humans with
coronary artery disease, and may account for a portion of the
beneficial effects of flavonoid-rich food on endothelial function,"
wrote the authors in the Journal of the American College of Nutrition.
European demand for tea extracts is currently surging, and this
has seen companies such as DSM, with its Teavigo boasting 95 per
cent purity of EGCG, and Taiyo International, with its Sunphenon
claiming more than 90 per cent purity, position themselves firmly
in specific catechin markets.
The researchers, led by Michael Widlansky from Boston University
School of Medicine in collaboration with researchers from DSM
Nutritional Products, state that epidemiological studies have
demonstrated the benefits of dietary flavonoid intake. These may
be related to improved endothelial function.
Widlansky and co-workers recruited 42 subjects to take part in
the double blind, placebo-controlled, crossover design study.
Subjects were randomly assigned to receive either an EGCG supplement
or a placebo.
Blood flow in the arm, so-called brachial artery flow-mediated
dilation (FMD), was measured by vascular ultrasound at baseline,
and again after two hours after an initial dose of EGCG (300 mg)
or placebo, and after two weeks of supplementation with EGCG (two
150 mg doses per day) or placebo. Before being crossed-over to
the other intervention, the subjects underwent a one-week washout
period.
Supplementation with the green tea extract was found to improve
FMD from 7.1 to 8.6 per cent two hours after the initial 300 milligram
dose, but was not significantly improved when measurements were
taken 14 hours after the end of the two weeks of supplementation.
Blood levels of EGCG mirrored the vascular function, said the
researchers, increasing from 2.6 to 92.8 nanograms per millilitre
after the initial 300 mg dose, but returning approximately to
baseline levels after two weeks (3.4 ng/ml).
The results add to an ever-growing body of science linking consumption
to a wide range of health benefits, including lower risk of certain
cancers, increased weight loss, improved heart health, and protection
against Alzheimer's.
Green tea contains between 30 and 40 per cent of water-extractable
polyphenols, while black tea (green tea that has been oxidized
by fermentation) contains between 3 and 10 per cent.
The four primary polyphenols found in fresh tealeaves are epigallocatechin
gallate (EGCG), epigallocatechin, epicatechin gallate, and epicatechin.
Source: Journal of the American College of Nutrition
Volume 26, Number 2, Pages 95-102
"Acute EGCG Supplementation Reverses Endothelial Dysfunction
in Patients with Coronary Artery Disease"
Authors: M.E. Widlansky, N.M. Hamburg, E. Anter, M. Holbrook,
D.F. Kahn, J.G. Elliott, J.F. Keaney, Jr., and J.A. Vita
Source: www.nutraingredients.com
Comment:
These results add to an ever-growing body of science linking
consumption of EGCG (a specific green tea extract) to the
improvement of endothelial function in humans with coronary
artery disease through the improvement of blood flow. Other
health benefits of EGCG include a lower risk of certain cancers,
increased weight loss, improved health, and protection against
Alzheimer’s.
Dr. Rath has shown in his research and clinical studies
that the root cause of atherosclerosis or arterial plaque
is a weak arterial wall structure due to chronic deficiency
of cellular nutrients - especially Vitamin C, lysine and
proline and EGCG. Our research clearly shows that the synergistic
combinations of these nutrients can aid in reversing or
stopping the atherosclerosis.
For more details on Dr. Rath’s research in heart
disease, please refer to Dr. Rath's publication "Why
animals don't get heart attacks...but people do!" and
our research web site http://www.drrathresearch.org/
for more details of Dr. Rath's research in heart disease. |
|